Speaker: Alan Wu, Ph.D
Professor Laboratory Medicine; Chief, Clinical Chemistry Laboratory, SFGH; Chief, Clinical Pharmacogenomics Laboratory, University of California San Francisco
In this webinar you will learn about the history and depth of the Opioid Crisis and the importance of the clinical laboratory in the patient continuum. In addition, you will learn to understand the important advantages of using urine drug-screening technology to eliminate cross-reactivity with other drugs, the benefits of oral fluid testing, and the role of LC-MS for confirmation testing of urine and oral fluids.
This webinar was hosted by AACC and sponsored by Thermo Fisher Scientific
Dr. Alan H.B. Wu received a B.S. in both Chemistry and Biology at Purdue University and a Ph.D. in Analytical Chemistry at the University of Illinois. He was a professor at the University of Texas and the University of Connecticut prior to his current position as a Professor of Laboratory Medicine at the University of California, San Francisco. He is the Section Chief of Clinical Chemistry, Toxicology and Pharmacogenomics at San Francisco General Hospital.